About Me

header ads

TRIUMF and Fusion Pharmaceuticals to develop next-generation radiopharmaceuticals

TRIUMF, Canada's particle accelerator center, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

from News Medical Medical Research News Feed https://ift.tt/3mqFqHn

Post a Comment

0 Comments